Marvipol Development Second Quarter 2025 Earnings: EPS: zł0.83 (vs zł0.032 in 2Q 2024)

Marvipol Development (WSE:MVP) Second Quarter 2025 Results

Key Financial Results

• Revenue: zł217.4m (up 440% from 2Q 2024).
• Net income: zł34.7m (up by zł33.4m from 2Q 2024).
• Profit margin: 16% (up from 3.3% in 2Q 2024). The increase in margin was driven by higher revenue.
• EPS: zł0.83 (up from zł0.032 in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Marvipol Development Earnings Insights

Looking ahead, revenue is expected to decline by 2.7% p.a. on average during the next 3 years, while revenues in the Real Estate industry in Poland are expected to grow by 12%.

Performance of the Polish Real Estate industry.

The company's shares are up 4.2% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Marvipol Development you should be aware of, and 2 of them are significant.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.